<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117730">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01964469</url>
  </required_header>
  <id_info>
    <org_study_id>00000940</org_study_id>
    <nct_id>NCT01964469</nct_id>
  </id_info>
  <brief_title>Consumer Access to Personal Health Information for Asthma Self-Management</brief_title>
  <acronym>ASMA</acronym>
  <official_title>Consumer Access to Personal Health Information for Asthma Self-Management Phase 2 (Pilot Implementation)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ontario Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ontario Ministry of Health and Long Term Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TELUS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canada Health Infoway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to compare Smart phone mobile device and/or web based application asthma
      action plan to the standard of care paper based asthma action plan within an asthma program.
      The Primary hypothesis: Health Outcome - The Breathe mobile health and web-based application
      improves asthma related quality of life more than conventional best practice
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a multi-centre, randomized controlled trial comparing a web-based (Smartphone
      mobile device, tablet and/or personal computer PC) asthma action plan application to best
      practice/usual care within an asthma program. A third external comparator arm will compare
      participants to all patients with asthma in Ontario using data obtained from the Ontario
      Asthma Surveillance Information System (OASIS) cohort, created from administrative data sets
      within the Institute for Clinical Evaluative Sciences (ICES). Subjects will be randomly
      assigned in blocks of four, stratified by site to, in a ratio of 1:1 intervention or control
      arms. The study will enrol approximately 400 patients in total at all study sites.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Health Outcome - Quality</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Health Outcome - The Breathe mobile health and web-based application improves asthma related quality of life more than conventional best practice.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality - Health Care Utilization</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Appropriateness of Care - Individuals with asthma who use the intervention will experience a decrease in the number of unplanned health system encounters</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Health Outcome - Quality</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Improvements in symptom profile greater than conventional best practice.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Written self-management action plan</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Usual Care: Evidence-based best practice within the primary care asthma program including written self-management action plan and regular clinical review.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mobile &amp; web based action plan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evidence-based best practice within the primary care asthma program, replacing the written action plan with the Breathe mobile health and web-based application.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Administrative data set</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Health services use will be evaluated comparatively against our intervention population and our control and we will include health services utilization data from one year prior randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mobile &amp; web-based action plan</intervention_name>
    <description>Evidence-based best practice primary care asthma program including asthma self-management education replacing the written self-management action plan with the Breathe mobile health and web-based application</description>
    <arm_group_label>mobile &amp; web based action plan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of asthma

          -  Age 18 of age or older

          -  Familiar with web technology

          -  Provide consent

          -  Understand/read/write English

        Exclusion Criteria:

        - Indication of other chronic lung diseases in the opinion of the physician that would
        impact their ability to participate in the trial or affect quality of life (CF, COPD,
        Bronchiectasis)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Licskai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lawson Health Research Institution</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Madonna J Ferrone</last_name>
    <phone>519-564-5900</phone>
    <email>argi@cogeco.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann Taite</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amherstburg FHT</name>
      <address>
        <city>Amherstburg</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chatham-Kent FHT</name>
      <address>
        <city>Chatham</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrow FHT</name>
      <address>
        <city>Harrow</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingston Hospital Asthma Clinic</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Taite</last_name>
    </contact>
    <investigator>
      <last_name>Diane Lougheed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leamington FHT</name>
      <address>
        <city>Leamington</city>
        <state>Ontario</state>
        <zip>N8H 1N8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
      <phone>519-564-5900</phone>
      <email>argi@cogeco.ca</email>
    </contact>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital Asthma Clinic</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <contact_backup>
      <last_name>Pam Wilton</last_name>
    </contact_backup>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sault St. Marie Group Health Centre</name>
      <address>
        <city>Sault St. Marie</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <contact_backup>
      <last_name>Janice Belanger</last_name>
    </contact_backup>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Windsor FHT</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madonna Ferrone</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Licskai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 14, 2013</lastchanged_date>
  <firstreceived_date>January 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Chris Licskai</investigator_full_name>
    <investigator_title>Associate Professor of Medicine, University of Western Ontario</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
